| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inovio Pharmaceuticals, Inc. (INO) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. INO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 86.6K | $116.1K | - | |
| CEO | 84.9K | $113.7K | - | |
| CFO | 26.1K | $35.0K | - | |
| Other | 18.1K | $24.2K | - | |
| Dir | 12.2K | $16.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2021 | Shea Jacqueline Elizabeth77 | Chief Operating Officer | Sale+OE | 45,049 | $12.03 | $541,718.68 | -41.9% | |
| Jan 15, 2021 | Kies Peter73 | CFO | Sale+OE | 30,000 | $10.02 | $300,558.00 | -20.1% | |
| Jan 5, 2021 | Zoth Lota S.59 | Director | Sale+OE | 961 | $9.48 | $9,110.28 | -5.9% | |
| Jan 4, 2021 | Benito Simon X80 | Director | Sale+OE | 2,750 | $9.00 | $24,750.00 | -5.1% | |
| Dec 15, 2020 | Kies Peter73 | CFO | Sale+OE | 20,000 | $10.69 | $213,706.00 | -14.4% | |
| Dec 15, 2020 | Weiner David B.82 | Director | Sale+OE | 17,500 | $10.71 | $187,351.50 | -2.1% | |
| Nov 10, 2020 | Humeau Laurent | Chief Scientific Officer | Sell | 19,466 | $9.75 | $189,793.50 | -44.3% | |
| Aug 10, 2020 | Humeau Laurent | Chief Scientific Officer | Sell | 19,467 | $19.06 | $371,004.03 | -30.7% | |
| Jul 30, 2020 | Kim Jong Joseph | Chief Executive Officer | Sell | 100,000 | $21.13 | $2,113,450.00 | -7.8% | |
| Jul 15, 2020 | Kies Peter73 | CFO | Sale+OE | 35,000 | $24.95 | $873,208.00 | -22.7% |